DAVID E. I. PYOTT - 16 Jun 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Director
Signature: /s/ Mike Ouimette, attorney-in-fact
Issuer symbol: PLRX
Transactions as of: 16 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 21 Jun 2022, 16:22:23 UTC
Previous filing: 26 May 2022
Next filing: 27 Feb 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (right to buy)	Award	$0	+15,000		$0.000000	15,000	16 Jun 2022	Common Stock	15,000	$6.80	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters beginning October 1st and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 16, 2022 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.

Content

25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters beginning October 1st and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 16, 2022 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.